Navigation Links
BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
Date:10/30/2009

ments that enable them to live longer, healthier, and fuller lives. Since 1923, Lilly has been an industry leader in pioneering therapies to help healthcare professionals improve the lives of people with diabetes, and research continues on innovative medicines to address the unmet needs of patients. For more information about Lilly's current diabetes products, visit www.lillydiabetes.com.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

This press release contains forward-looking statements about Amylin and Lilly. Actual results could differ materially from those discussed or implied in this press release due to a number of risks and uncertainties, including the risk that BYETTA and the revenues generated from BYETTA may be affected by competition; unexpected new data; safety and technical issues; clinical trials not confirming previous results; pre-clinical trials not predicting future results; label expansion requests not being submitted in a timely manner or receiving regulatory approval; approved label expansions not producing the results we expect, or manufacturing and supply issues. The potential for BYETTA may also be affected by government and commercial reimbursement and pricing decisions, the pace of market acceptance, or scientific, regulatory and other issues and risks inherent in the commercialization of pharmaceutical products. These and additional risks and uncertainties are described more fully in Amylin's and Lilly's most recent SEC f
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA
2. Surveyed Experts Indicate That Byetta LAR and Victoza Have Advantages Over Actos in the Treatment of Type 2 Diabetes
3. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
4. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
5. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
6. Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
7. Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer
8. EVICEL(TM) Fibrin Sealant (Human) Approved for General Hemostasis in Surgery
9. Clexane(R)/Lovenox(R) Approved in Japan
10. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
11. Center for Molecular Medicine Among First to Offer New FDA-Approved Test to Aid in Treatment of Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014  United Therapeutics Corporation (NASDAQ: ... release its second quarter 2014 financial results before ... United Therapeutics will host a half-hour teleconference ... Eastern Time.  The teleconference is accessible by dialing ... of the teleconference will be available for one ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Biofeedback ... hyperactivity disorder (ADHD) is diagnosed, selecting medication to best ... error. Analyzing brain patterns by using electroencephalography (EEG) can ... and thus lower the risk of adverse drug events. ... and Biomarkers” in the current issue of the ...
(Date:7/21/2014)... Lawrence Livermore National Laboratory ... Las Positas College (LPC) recently established a 24-month ... training for veterans, officials recently announced. , The ... is designed to help veterans develop the ... and establishes a pipeline of qualified candidates for ...
(Date:7/21/2014)... of Arts and Sciences has received a major ... , Mathew M. Maye, associate professor of chemistry, ... the National Science Foundation (NSF). The award supports ... the results of which may impact gas storage, ... , Maye,s approach is novel, in that he ...
Breaking Biology Technology:Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 2Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 3Engineering Program Established for Veterans 2Engineering Program Established for Veterans 3Syracuse University chemist to use NSF grant to study materials chemistry, nanoscience 2
... Feb. 19 NeurogesX, Inc.,(Nasdaq: NGSX ), ... therapies, announced today that it is scheduled to ... Growth Stock Conference in,Laguna Niguel, CA on February ... will be presenting and Stephen Ghiglieri, Chief,Financial Officer, ...
... BEIJING, Feb. 19 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex:,SVA), ... it,will hold its 2007 Annual Meeting of Shareholders on ... meeting will be held concurrently at,No. 39 Shangdi Xi ... Temple,Street, St. John,s, Antigua. All shareholders of record as ...
... Pharmion Corporation,(Nasdaq: PHRM ) today reported financial ... For the year, net sales totaled $267.3 million,compared to ... of,Vidaza(R) (azacitidine for injection) totaled $165.3 million for 2007,compared ... of Vidaza totaled,$131.4 million in 2007, compared to $130.6 ...
Cached Biology Technology:NeurogesX to Present at Roth 2008 OC Growth Stock Conference 2NeurogesX to Present at Roth 2008 OC Growth Stock Conference 3Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders 2Pharmion Corporation Announces 2007 Operating Results 2Pharmion Corporation Announces 2007 Operating Results 3Pharmion Corporation Announces 2007 Operating Results 4Pharmion Corporation Announces 2007 Operating Results 5Pharmion Corporation Announces 2007 Operating Results 6
(Date:7/21/2014)... areas across Riau province on Sunday, July 20, indicating ... decline in rainfall. The number of detected hotspots ... been reported one day prior, which had reached only ... regencies and municipalities, most of which were in northern ... creates could potentially spread via winds to Malaysia and ...
(Date:7/21/2014)... process that uses extracts from seeds of Moringa oleifa ... by 90% to 99%. The hardy trees that are ... Africa, Asia, and Latin America. , The protocol, which ... review, is low-cost and efficient, making it especially ... countries who are presently drinking highly turbid and contaminated ...
(Date:7/21/2014)... reveals that mesenchymal (mezz-EN-chem-uhl) stem cells (MSCs) help rejuvenate ... MSCs into mouse leg muscles prior to several bouts ... during resistance training in humans that result in mild ... of repair and enhance the growth and strength of ... findings, described in the journal Medicine and Science ...
Breaking Biology News(10 mins):Stem cells aid muscle repair and strengthening after resistance exercise 2
... activated when we choose to suppress an emotion, compared to ... new study from the UCL Institute of Cognitive Neuroscience and ... Brain Structure and Function , the researchers scanned the brains ... activated when choosing for oneself to suppress an emotion. They ...
... among a national group of 87 newly elected fellows ... Tweten, OU Health Sciences Center in Oklahoma City, and ... highly-selective, peer-review process, based on their records of scientific ... Tweten, George Lynn Cross Research Professor in the Department ...
... that R. Graham Cooks, the Henry Bohn Hass Distinguished ... of the 2013 Dreyfus Prize in the Chemical Sciences, ... awarded biennially, consists of $250,000, a citation, and a ... University in the fall and will feature a lecture ...
Cached Biology News:Study finds brain system for emotional self-control 2OU microbiologists elected as fellows in the American Academy of Microbiology 2R. Graham Cooks wins Dreyfus Prize in the Chemical Sciences 2
Form: Ready to use Applications: ELISA...
Form: Ready to use Applications: ELISA...
ANTI S. GROUP AG:H...
Recorder REC-111 single-channel, 1. Category: Chromatography Systems & Accessories, Systems....
Biology Products: